Yezo virus, new disease that infects humans, discovered in japan.
Scientists have isolated a new orthonairovirus from two patients showing acute febrile illness with thrombocytopenia and leukopenia after tick bite in Hokkaido, Japan.
They cause sometimes fatal febrile illnesses in humans and other animals.
The availability of data can paralyze a company and its effort to bring software-centric products and services to market. To solve this issue, two-year-old data startup Rendered.ai is generating synthetic data for the satellite, medical, robotics and automotive industries.
At its most broad, synthetic data is manufactured rather than gathered from the real world. “When we use the term synthetic data what we really mean is engineered simulated datasets, and in particular, we focus on a physics-based simulation,” Rendered.ai CEO Nathan Kundtz explained in a recent interview with TechCrunch.
Kundtz received his PhD in physics from Duke University and cut his teeth in the space industry, heading the satellite antenna developer Kymeta Corporation. After leaving that company, he started working with other small space companies, when he noticed what he called a “chicken and egg” problem.
Driving this revolution has been a new breed and wave of founders and startups that merge the worlds of technology and bio — importantly, not just the old world of biotech (or a narrow definition of tech in bio as only “digital health”), but something much broader, bigger, and blending both worlds. In short, biology — enabled by technology — is eating the world. This has not only changed how we diagnose, treat, and manage disease, but has been changing the way we access, pay for, and deliver care in the healthcare system. It is now entering into manufacturing, food, and several other industries as well. Bio is becoming a part of everything.
This new era of industrialized bio — enabled by AI as well as an ongoing, foundational shift in biology from empirical science to more engineered approaches — will be the next industrial revolution in human history. And propelling it forward is an enormous new driving force, the novel coronavirus SARS-CoV-2, its ever-evolving strains, and the resulting COVID-19 disease pandemic and response — which I believe is analogous to our generation’s World War II (WW2). In other words: a massive global upheaval, but that later led to unprecedented innovation and significant new players.
Continue reading “The Coming Age for Tech x Bio: The ‘Industrial Bio Complex’” »
Although the idea of having a small device implanted in our skulls might sound terrifying to some, deep brain stimulation has had a successful past in other brain disorders such as Parkinson’s disease and epilepsy.
Depression can be a frighteningly relentless condition. Luckily, researchers around the world are constantly working on new treatment options, such as a newly designed brain implant for resistant depression.
Continue reading “World-First Brain Implant Successfully Treats Resistant Depression in a Patient” »
AstraZeneca said on Tuesday that it had asked the Food and Drug Administration to grant emergency authorization for an antibody treatment to prevent Covid-19 in people who are at high risk of the disease. If authorized, it would become the first such preventive treatment to be available in the United States, the company said.
The company said in a statement that the treatment had reduced the risk of symptomatic Covid-19 by 77 percent in a trial in which most participants either had other medical conditions that placed them at greater risk of severe illness or were not producing sufficient antibodies after vaccination.
It said the treatment could be used in conjunction with vaccines in people with weaker immune systems. Other antibody treatments in use in the United States, including one developed by the drug maker Regeneron, have mainly been used to treat people who are already infected with the coronavirus.
“To slow the ongoing loss of animal and plant life in the United States, President Biden signed an executive order in January 2,021 stating his administration’s goal to conserve 30% of U.S. lands and water by 2030. This bold, science-based initiative – America the Beautiful – is the first ever nationwide conservation effort to address both climate change and biodiversity loss.” https://www.futuretimeline.net/images/robot-future-timeline.jpg
The U.S. Fish and Wildlife Service (USFWS) has declared 23 species extinct, due to a combination of development, invasive species, logging and pollution.
The agency is recommending that the species be removed from the Endangered Species Act (ESA), the primary law in the United States for protecting and recovering imperilled organisms and the ecosystems they depend on. For the animals proposed for delisting, the protections of the ESA came too late.
Continue reading “23 species declared extinct in the U.S.” »
Comprehensive health, social services and economic well-being for american indian and alaska native elders — larry curley, executive director, national indian council on aging.
Mr. Larry Curley is Executive Director of The National Indian Council on Aging (https://www.nicoa.org/), a 501©(3) nonprofit organization founded in 1976 by members of the National Tribal Chairmen’s Association who called for a national organization focused on the needs of aging American Indian and Alaska Native elders. The mission of NICOA is to advocate for improved comprehensive health, social services and economic well-being for American Indian and Alaska Native elders.
Diagnosing, Treating, And Preventing Neglected Tropical Diseases — Dr. Maria Elena Bottazzi, BCM National School of Tropical Medicine, Baylor University.
Dr. Maria Elena Bottazzi (https://www.bcm.edu/people-search/maria-bottazzi-18431) is Distinguished Professor of Biology, Associate Dean of the National School of Tropical Medicine, and Professor in the Departments of Pediatrics, Molecular Virology and Microbiology, Integrative Molecular and Biomedical Sciences, and Translational Biology and Molecular Medicine, at Baylor College of Medicine.
Your DNA is in a database.
Your genetic code is probably already in a database, without you ever giving a sample or permission. This video is sponsored by Brilliant. The first 200 people to sign up via https://brilliant.org/veritasium get 20% off a yearly subscription.
Continue reading “Catching Criminals With Their Relative’s DNA” »
Sickle-cell disease is incurable and affects 15,000 people in the UK.
And the National Institute for Health and Care Excellence said the hope of reducing health inequalities for black people, who are predominantly affected and often have poorer health to start with, made the drug worth recommending.
It called it “an innovative treatment”.
Continue reading “First new treatment for sickle cell in 20 years” »
